Opthea Ltd has released a press release.
Opthea: Half Yearly Report and Accounts
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Opthea
- Opthea Reports Half-Year Results and Business Update
- Opthea Completes Enrollment in First Trial of Sozinibercept
- Opthea to Receive US$35M Commitment and Additional US$50M
- Opthea receives A$8.8 million R&D Tax Incentive
- 2023 AGM Chairmans Address
Later from Opthea
- Opthea Corporate Presentation - March 2024
- Opthea Key Opinion Leader Even on Sozinibercept
- Opthea Corporate Presentation - April 2024
- Opthea Completes Enrollment in Phase 3 Clinical Program
- Opthea to Present at Clinical Trials at the Summit Meeting
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea